X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48) 48
clinical neurology (44) 44
female (40) 40
male (39) 39
aged (36) 36
middle aged (35) 35
peripheral vascular disease (33) 33
index medicus (32) 32
stroke (25) 25
risk factors (23) 23
adult (18) 18
aged, 80 and over (17) 17
neurosciences (15) 15
prevention (11) 11
treatment outcome (10) 10
cerebral infarction (9) 9
medicine, general & internal (9) 9
prevalence (9) 9
retrospective studies (9) 9
time factors (9) 9
risk (8) 8
stroke - etiology (8) 8
age factors (7) 7
aspirin (7) 7
diagnosis (7) 7
ischemia (7) 7
latin america (7) 7
platelet aggregation inhibitors - therapeutic use (7) 7
recurrence (7) 7
stroke - epidemiology (7) 7
acute ischemic-stroke (6) 6
atherosclerosis (6) 6
atrial-fibrillation (6) 6
infection (6) 6
ischemic-stroke (6) 6
mortality (6) 6
neurology (6) 6
registry (6) 6
risk-factors (6) 6
stroke - drug therapy (6) 6
anticoagulants (5) 5
classification (5) 5
clinical trials (5) 5
disease (5) 5
global burden (5) 5
ischemic stroke (5) 5
medical research (5) 5
platelet aggregation inhibitors - adverse effects (5) 5
risk assessment (5) 5
stroke - complications (5) 5
stroke - prevention & control (5) 5
abridged index medicus (4) 4
adolescent (4) 4
antithrombotic therapy (4) 4
argentina (4) 4
aspirin - therapeutic use (4) 4
association (4) 4
atrial fibrillation (4) 4
blood flow velocity (4) 4
brain ischemia - drug therapy (4) 4
brain ischemia - epidemiology (4) 4
case-control studies (4) 4
cerebral arteries - physiology (4) 4
chi-square distribution (4) 4
cryptogenic stroke (4) 4
design (4) 4
double-blind method (4) 4
drug therapy (4) 4
epidemiology (4) 4
kaplan-meier estimate (4) 4
management (4) 4
medicine, experimental (4) 4
multivariate analysis (4) 4
population (4) 4
prognosis (4) 4
psychiatry (4) 4
sex factors (4) 4
stroke - diagnosis (4) 4
stroke patients (4) 4
subarachnoid hemorrhage (4) 4
surveys and questionnaires (4) 4
young adult (4) 4
young-adults (4) 4
acute disease (3) 3
acute myocardial-infarction (3) 3
angiography (3) 3
antiphospholipid antibodies (3) 3
argentina - epidemiology (3) 3
aspirin - adverse effects (3) 3
bleeding (3) 3
brain ischemia - complications (3) 3
cardiovascular diseases (3) 3
care and treatment (3) 3
cerebral infarction - microbiology (3) 3
cerebral-ischemia (3) 3
cerebrovascular disorders - physiopathology (3) 3
clinical medicine (3) 3
clopidogrel (3) 3
dosage and administration (3) 3
endothelial-cells (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurology, ISSN 0028-3878, 11/2018, Volume 91, Issue 20, pp. 905 - 906
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 15, pp. 1404 - 1413
Patients with atherosclerotic vascular disease were randomly assigned to receive the thrombin antagonist vorapaxar or placebo. Vorapaxar reduced the rate of... 
TRIAL | STROKE | MEDICINE, GENERAL & INTERNAL | PROTEASE-ACTIVATED RECEPTORS | CLOPIDOGREL | ANTITHROMBOTIC AGENTS | SAFETY | TOLERABILITY | DOUBLE-BLIND | ACUTE CORONARY SYNDROMES | ASPIRIN | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Computer Science | Medical Imaging
Journal Article
by Kasner, Scott E and Kasner, SE and Swaminathan, Balakumar and Lavados, Pablo and Lavados, P and Sharma, M and Sharma, Mukul and Muir, Keith and Muir, KW and Veltkamp, Roland and Veltkamp, R and Ameriso, Sebastian F and Ameriso, SF and Endres, M and Endres, Matthias and Lutsep, H and Lutsep, Helmi and Messé, Steven R and Spence, J David and Spence, D and Nedeltechev, Krassen and Perera, Kanjana and Perera, K and Santo, G and Santo, Gustavo and Olavarria, Veronica and Olavarria, V and Lindgren, Arne and Lindgren, A and Bangdiwala, Shrikant and Shoamanesh, Ashkan and Shoamanesh, A and Berkowitz, Scott D and Berkowitz, SD and Mundl, Hardi and Mundl, H and Connolly, Stuart J and Connolly, SJ and Hart, Robert G and Hart, RG and Abdelhamid, N and Abdul Rahman, D and Abdul-Saheb, M and Abreu, P and Abroskina, M and Abu Ahmad, F and Accassat, S and Acciaresi, M and Adami, A and Ahmad, N and Ahmed, F and Alberto Hawkes, M and Alemseged, F and Ali, A and Altavilla, R and Alwis, L and Amarenco, P and Amaro, S and Amaya Sanchez, LE and Amelia Pinto, A and Amin, H and Amino, T and Amjad, AK and Anagnostou, E and Andersen, G and Anderson, C and Anderson, DC and Andrea Falco, M and Andres Mackinnon, F and Andreu, D and Androulakis, M and Angel Gamero, M and Angel Saredo, G and Angeles Diaz, R and Angels Font, M and Anticoli, S and Arauz, A and Arauz Gongora, AA and Araya, P and Arenillas Lara, JF and Arias Rivas, S and Arnold, M and Augustin, S and Avelar, W and Azevedo, E and Babikian, V and Bacellar, A and Badalyan, K and Bae, HJ and Baez Martinez, EM and Bagelmann, H and Bailey, P and Bak, Z and Baker, M and Balazs, A and Baldaranov, D and Balogun, I and Balueva, T and Bankuti, Z and Bar, M and ... and NAVIGATE ESUS Investigators and Klinisk strokeforskning and EpiHealth: Epidemiology for Health and Clinical Stroke Research Group and Lund University and Lunds universitet
The Lancet Neurology, ISSN 1474-4422, 12/2018, Volume 17, Issue 12, pp. 1053 - 1060
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 23, pp. 2191 - 2201
In a randomized trial involving patients who had a first stroke from an embolus of unknown source, rivaroxaban at a daily dose of 15 mg did not result in a... 
CRYPTOGENIC STROKE | TRIALS | MEDICINE, GENERAL & INTERNAL | DESIGN | METAANALYSIS | EFFICACY | WARFARIN | SAFETY | ANTITHROMBOTIC THERAPY | FORAMEN OVALE CLOSURE | ATRIAL-FIBRILLATION | Stroke - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Brain Ischemia - prevention & control | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Embolism - drug therapy | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Prevention | Rivaroxaban | Complications and side effects | Dosage and administration | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Neurosciences | Embolisms | Stenosis | Bleeding | Design | Ischemia | Atherosclerosis | Drug dosages | Research centers | Anticoagulants | Medical research | Stroke | Aspirin | Internal medicine | Research & development--R&D | Thrombosis | Patients | Embolism | Blood clots | Medicine | Neurology | Hospitals | Life Sciences | Human health and pathology | metaanalysis | atrial-fibrillation | foramen ovale closure | antithrombotic therapy | Klinisk medicin | efficacy | warfarin | Clinical Medicine | trials | safety | design | cryptogenic stroke | General & Internal Medicine
Journal Article